AK Medical reports strong profit growth for first half of 2025

For the six months ended June 30, 2025, AK Medical Holdings Limited reported revenue of RMB694.2 million, a 5.6% increase from RMB657.1 million in the same period of 2024. Profit attributable to equity shareholders surged by 15.3% to RMB160.6 million, up from RMB139.3 million in the prior year, primarily attributed to revenue growth. Basic and diluted earnings per share stood at RMB0.14, compared to RMB0.12 in 2024.

The company's gross profit rose by 3.0% to RMB410.3 million. Revenue from hip replacement implants increased by 14.0% to RMB409.7 million, while spinal and trauma implants revenue decreased by 26.5% to RMB50.7 million. Digital orthopedics customized products and services also saw a 3.9% increase, contributing RMB18.4 million to the revenue.

The group's net current assets increased by RMB263.9 million to RMB1,845.5 million. The gearing ratio as of June 30, 2025, was approximately 5.2%. The board did not recommend an interim dividend for the period.